Repaglinide + Metformin Hydrochloride - Antidiabetic Combination Products
Drug Name:
Repaglinide + Metformin Hydrochloride - Antidiabetic Combination Products
List Of Brands:
Indication Type Description:
Indication:
Type II Diabetes not responsive to diet
BRAND- PRANDIN-
NOVO NORDISK
TABLETS 0.5mg WHITE 100s, 500s and 1000s
1mg YELLOW in 100s, 500s, and 1000s
2mg PEACH in 100s, 500s, and 1000s
INDICATION- TYPE 2 DIABETES MELITUS
Dosages/ Overdosage Etc:
Indication-
Type II Diabetes not responsive to diet
Dosage-
Dosage should be individualized.
Repagalinide can be administered 2 to 3 times daily up to a maximum daily dose of repagalinde
10mg/metformin 2500mg.
No more than reglitinide 4mg/ metformin 1000mg should be taken per meal
Initiation and maintenace of combination therapy should be individualized
Patients inadequately controlled with metformin monotherapy-
Recommended starting dose is repalglinide/metformin is 1mg/metformin 500mg administered
twice daily with meals, with gradual escalation based on glycemic response to reduce risk of
hypoglycemia with repaglinide